NextCell Pharma AB (STO:NXTCL)
Sweden · Delayed Price · Currency is SEK 0.9500
-0.0200 (-2.06%)
Jul 3, 2026, 5:16 PM CET
NextCell Pharma AB Market Cap
NextCell Pharma AB has a market cap or net worth of 120.07 million as of July 2, 2026. Its market cap has increased by 8.23% in one year.
Market Cap
120.07M
Enterprise Value
87.74M
Revenue
9.24M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.95
Market Cap Chart
Since July 13, 2017, NextCell Pharma AB's market cap has increased from 33.03M to 120.07M, an increase of 263.57%. That is a compound annual growth rate of 15.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 3, 2026 | 120.07M | 47.46% |
| Dec 30, 2025 | 81.43M | -60.77% |
| Dec 30, 2024 | 207.58M | 129.58% |
| Dec 29, 2023 | 90.42M | -62.64% |
| Dec 30, 2022 | 242.03M | -9.28% |
| Dec 30, 2021 | 266.79M | -35.76% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jul 13, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Diamyd Medical AB | 168.93M |
| Nanologica AB | 163.07M |
| Active Biotech AB | 149.07M |
| Simris Group AB (PUBL) | 120.94M |
| Alligator Bioscience AB | 115.32M |
| Ascelia Pharma AB | 107.90M |
| Biovica International AB | 105.09M |
| OncoZenge AB | 101.43M |